Loss of Hormone Receptor Expression after Exposure to Fluid Shear Stress in Breast Cancer Cell Lines.
Jonathan CucciaBraulio Andrés Ortega QuesadaEthan P LittlefieldAlejandra M HamMatthew E BurowAdam T MelvinElizabeth C MartinPublished in: International journal of molecular sciences (2024)
Following metastatic spread, many hormone receptor positive (HR + ) patients develop a more aggressive phenotype with an observed loss of the HRs estrogen receptor (ER) and progesterone receptor (PR). During metastasis, breast cancer cells are exposed to high magnitudes of fluid shear stress (FSS). Unfortunately, the role for FSS on the regulation of HR expression and function during metastasis is not fully understood. This study was designed to elucidate the impact of FSS on HR + breast cancer. Utilizing a microfluidic platform capable of exposing breast cancer cells to FSS that mimics in situ conditions, we demonstrate the impact of FSS exposure on representative HR + breast cancer cell lines through protein and gene expression analysis. Proteomics results demonstrated that 540 total proteins and 1473 phospho-proteins significantly changed due to FSS exposure and pathways of interest included early and late estrogen response. The impact of FSS on response to 17β-estradiol (E2) was next evaluated and gene expression analysis revealed repression of ER and E2-mediated genes ( PR and SDF1 ) following exposure to FSS. Western blot demonstrated enhanced phosphorylation of mTOR following exposure to FSS. Taken together, these studies provide initial insight into the effects of FSS on HR signaling in metastatic breast cancer.
Keyphrases
- estrogen receptor
- breast cancer cells
- genome wide identification
- poor prognosis
- metastatic breast cancer
- binding protein
- end stage renal disease
- small cell lung cancer
- high throughput
- ejection fraction
- mass spectrometry
- squamous cell carcinoma
- cell proliferation
- single cell
- young adults
- dna methylation
- transcription factor
- prognostic factors
- peritoneal dialysis
- patient reported outcomes
- amino acid
- protein kinase
- protein protein
- childhood cancer